View in EDS HTML Full Text PDF Full Text

Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.

Saved in:
Bibliographic Details
Title: Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.
Authors: Thaçi D; Institute and Comprehensive Center for Inflammation Medicine, University Hospital of Lübeck, Lübeck, Germany., Vender R; Dermatrials Research Inc., Hamilton, ON, Canada., de Rie MA; Department of Dermatology, Amsterdam University Medical Centres, Amsterdam, the Netherlands., Conrad C; Department of Dermatology, Lausanne University Hospital, Switzerland., Pariser DM; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA.; Virginia Clinical Research, Inc., Norfolk, VA, USA., Strober B; Yale University, New Haven, CT, USA.; Central Connecticut Dermatology Research, Cromwell, CT, USA., Vanvoorden V; UCB Pharma, Brussels, Belgium., Wang M; UCB Pharma, Raleigh, NC, USA., Madden C; UCB Pharma, Raleigh, NC, USA., de Cuyper D; UCB Pharma, Brussels, Belgium., Kimball AB; Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Source: The British journal of dermatology [Br J Dermatol] 2023 Jan 23; Vol. 188 (1), pp. 22-31.
Publication Type: Randomized Controlled Trial; Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0004041 Publication Model: Print Cited Medium: Internet ISSN: 1365-2133 (Electronic) Linking ISSN: 00070963 NLM ISO Abbreviation: Br J Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36689515
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Thaçi+D%22">Thaçi D</searchLink>; Institute and Comprehensive Center for Inflammation Medicine, University Hospital of Lübeck, Lübeck, Germany.<br /><searchLink fieldCode="AU" term="%22Vender+R%22">Vender R</searchLink>; Dermatrials Research Inc., Hamilton, ON, Canada.<br /><searchLink fieldCode="AU" term="%22de+Rie+MA%22">de Rie MA</searchLink>; Department of Dermatology, Amsterdam University Medical Centres, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Conrad+C%22">Conrad C</searchLink>; Department of Dermatology, Lausanne University Hospital, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pariser+DM%22">Pariser DM</searchLink>; Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA.; Virginia Clinical Research, Inc., Norfolk, VA, USA.<br /><searchLink fieldCode="AU" term="%22Strober+B%22">Strober B</searchLink>; Yale University, New Haven, CT, USA.; Central Connecticut Dermatology Research, Cromwell, CT, USA.<br /><searchLink fieldCode="AU" term="%22Vanvoorden+V%22">Vanvoorden V</searchLink>; UCB Pharma, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Wang+M%22">Wang M</searchLink>; UCB Pharma, Raleigh, NC, USA.<br /><searchLink fieldCode="AU" term="%22Madden+C%22">Madden C</searchLink>; UCB Pharma, Raleigh, NC, USA.<br /><searchLink fieldCode="AU" term="%22de+Cuyper+D%22">de Cuyper D</searchLink>; UCB Pharma, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Kimball+AB%22">Kimball AB</searchLink>; Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220004041%22">The British journal of dermatology</searchLink> [Br J Dermatol] 2023 Jan 23; Vol. 188 (1), pp. 22-31.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0004041 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2133 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070963%22">00070963 </searchLink><i>NLM ISO Abbreviation: </i>Br J Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36689515
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/bjd/ljac021
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 22
    Titles:
      – TitleFull: Safety and efficacy of bimekizumab through 2 years in patients with moderate-to-severe plaque psoriasis: longer-term results from the BE SURE randomized controlled trial and the open-label extension from the BE BRIGHT trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Thaçi D
      – PersonEntity:
          Name:
            NameFull: Vender R
      – PersonEntity:
          Name:
            NameFull: de Rie MA
      – PersonEntity:
          Name:
            NameFull: Conrad C
      – PersonEntity:
          Name:
            NameFull: Pariser DM
      – PersonEntity:
          Name:
            NameFull: Strober B
      – PersonEntity:
          Name:
            NameFull: Vanvoorden V
      – PersonEntity:
          Name:
            NameFull: Wang M
      – PersonEntity:
          Name:
            NameFull: Madden C
      – PersonEntity:
          Name:
            NameFull: de Cuyper D
      – PersonEntity:
          Name:
            NameFull: Kimball AB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 01
              Text: 2023 Jan 23
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2133
          Numbering:
            – Type: volume
              Value: 188
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The British journal of dermatology
              Type: main
ResultId 1